Rosenberg, Anna http://orcid.org/0000-0003-1456-7991
Solomon, Alina
Soininen, Hilkka
Visser, Pieter Jelle
Blennow, Kaj
Hartmann, Tobias
Kivipelto, Miia
Soininen, Hilkka
Hallikainen, Ilona
Hallikainen, Merja
Helisalmi, Seppo
Lappalainen, Tarja
Liu, Yawu
Paajanen, Teemu
Kivipelto, Miia
Solomon, Alina
Wahlund, Lars-Olof
Freund-Levi, Yvonne
Hagman, Göran
Blennow, Kaj
Hartmann, Tobias
Fassbender, Klaus
Riemenschneider, Matthias
Grimm, Marcus O. W.
Klees-Rollmann, Aline
Luley, Maxine
Lyros, Epameinondas
Schomburg, Robert
Ramelli, Daniela
Kennel, Jennifer
Frölich, Lutz
Hausner, Lucrezia
Laske, Christoph
Leyhe, Thomas
Mychajliw, Christian
Koehler, Niklas
Schiekofer, Stephan
Klünemann, Hans
Schröder, Johannes
Lütjohann, Dieter
Visser, Pieter Jelle
Scheltens, Philip
van Rossum, Ineke
Scheltens, Nienke
Bertens, Daniela
ten Kate, Mara
Barkhof, Frederik
Ingala, Silvia
Henselmans, Johanna M. L.
Roks, Gerwin
van Hees, Anneke M. J.
van Oudenhoven, Floor M.
Hendrix, Suzanne B.
Ellison, Noel
,
Funding for this research was provided by:
Seventh Framework Programme (211696)
EU Joint Programme – Neurodegenerative Disease Research (MIND-AD grant, MIND-AD grant, MIND-AD grant, EURO-FINGERS grant, EURO-FINGERS grant)
Kuopion Yliopistollinen Sairaala (EVO/VTR grant)
European Research Council (804371)
Academy of Finland (317465, 287490)
Alzheimerfonden (AF-742881)
Hjärnfonden (FO2017-0243)
Stockholms Läns Landsting (ALFGBG-715986)
Suomen Kulttuurirahasto
Suomen Aivosäätiö
Maire Taposen Säätiö
Emil Aaltosen Säätiö
Center for Innovative Medicine (CIMED) at Karolinska Institute
Stiftelsen Stockholms sjukhem
Vetenskapsrådet
Article History
Received: 12 November 2020
Accepted: 23 February 2021
First Online: 25 March 2021
Declarations
:
: Ethical approval was granted by local ethics committees at each study site, and written informed consent was obtained from all participants and study partners. Approval was obtained from the following committees: Ethics committee of the Hospital District of Northern Savo in Finland (Pohjois-Savon sairaanhoitopiirin tutkimuseettinen toimikunta), the Stockholm Regional Ethical Review Board in Sweden (Regionala etikprövningsnämnden i Stockholm), the Medical Ethical Committee of the VU University Medical Center Amsterdam in the Netherlands (Medisch Ethische Toetsingscommissie VU medisch centrum), and the ethical committees of University of Regensburg (Fakultät Medizin Ethikkommission Universität Regensburg), Eberhards-Karls-University of Tübingen and Tübingen University Hospital Clinic (Ethik-Kommission an der Medizinischen Fakultät der Eberhard-Karls-Universität und am Universitätsklinikum Tübingen), Heidelberg University (Ethikkommission Medizinische Fakultät Heidelberg), the Medical faculty in Mannheim (Medizinische Fakultät Mannheim Medizinische Ethik-Kommission II), and Saarland University (Ethik-Kommission Ärtzekammer des Saarlandes) in Germany.
: Not applicable.
: The LipiDiDiet consortium received funding by Danone Nutricia Research for the intervention period from 25 to 96 months, and the consortium distributed the funding to their members to conduct the trial and analysis. HS reports personal fees from ACI and MERCK (advisor), outside the submitted work. KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (disclosures not relevant for the submitted work). AR, AS, PJV, TH, and MK report no competing interests.